NDC 65862-552

Lamivudine

Lamivudine

Lamivudine is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Lamivudine.

Product ID65862-552_01846f49-a281-4b00-8168-fee1bdc3fb94
NDC65862-552
Product TypeHuman Prescription Drug
Proprietary NameLamivudine
Generic NameLamivudine
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2011-11-17
Marketing CategoryANDA / DRUG FOR FURTHER PROCESSING
Application NumberANDA202032
Labeler NameAurobindo Pharma Limited
Substance NameLAMIVUDINE
Active Ingredient Strength150 mg/1
Pharm ClassesHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 65862-552-10

6 BLISTER PACK in 1 CARTON (65862-552-10) > 10 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Start Date2011-11-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65862-552-10 [65862055210]

Lamivudine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA202032
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-11-17

NDC 65862-552-60 [65862055260]

Lamivudine TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA202032
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-11-17

Drug Details

Active Ingredients

IngredientStrength
LAMIVUDINE150 mg/1

Medicade Reported Pricing

65862055260 LAMIVUDINE 150 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Lamivudine" or generic name "Lamivudine"

NDCBrand NameGeneric Name
0904-6583LAMIVUDINElamivudine
10135-605LamivudineLamivudine
31722-001lamivudinelamivudine
31722-752LamivudineLamivudine
31722-753LamivudineLamivudine
31722-754LamivudineLamivudine
33342-001LamivudineLamivudine
33342-002LamivudineLamivudine
68180-603LamivudineLamivudine
68180-602LamivudineLamivudine
69097-167LAMIVUDINELAMIVUDINE
69097-166LAMIVUDINELAMIVUDINE
70518-0540LamivudineLamivudine
70518-0440LamivudineLamivudine
70518-0513LamivudineLamivudine
70518-0690LamivudineLamivudine
70518-1083LamivudineLamivudine
70518-1084LamivudineLamivudine
70518-1634LamivudineLamivudine
70518-1933LamivudineLamivudine
50268-460LamivudineLamivudine
50268-459LamivudineLamivudine
50742-623LamivudineLamivudine
50742-624LamivudineLamivudine
51293-832LamivudineLamivudine
53808-0843LAMIVUDINELAMIVUDINE
53808-0844LAMIVUDINELAMIVUDINE
54838-566LamivudineLamivudine
57237-274LamivudineLamivudine
60429-354LAMIVUDINELAMIVUDINE
60687-362LamivudineLamivudine
60429-353LAMIVUDINELAMIVUDINE
60505-3250LamivudineLamivudine
60505-3252LAMIVUDINELAMIVUDINE
60505-3251LAMIVUDINELAMIVUDINE
63629-5014LamivudineLamivudine
64380-711LamivudineLamivudine
64330-001LamivudineLamivudine
64380-710LamivudineLamivudine
65862-055LamivudineLamivudine
65862-026LamivudineLamivudine
65862-552LamivudineLamivudine
65862-553LamivudineLamivudine
65862-025LamivudineLamivudine
66993-478LamivudineLamivudine
69967-003LamivudineLamivudine
69967-004LamivudineLamivudine
70518-2067LamivudineLamivudine
70518-2070LamivudineLamivudine
0173-0662EPIVIRlamivudine

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.